Found 28 Enz. Inhib. hit(s) with all data for entry = 930 TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 39nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 27nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 26nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 23nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 22nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 31nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 29nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 5nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 6nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 11nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 3nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 3nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 4nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 9nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 8nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 8nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 9nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 7nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 33nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 133nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 150nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 13nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 24nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 4nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 4nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 49nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 45nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 26nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
